Investing Profile
Krishna Polu
Your Intro Paths to Krishna Polu
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Krishna is a member of
Stanford University Network
507 CONNECTIONS
Stanford University Graduate School of Business Network
294 CONNECTIONS
Harvard Medical School Network
20 CONNECTIONS
Find Krishna Polu on
cbCurrent Investing Position
Red Tree Venture Capital Principal
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
2
Krishna Polu is on these Sector & Stage Rankings
Therapeutics (Pre-seed)Pharmaceuticals (Pre-seed)Therapeutics (Seed)Therapeutics (Pre-seed)Digital Health (Pre-seed)ClimateTech/CleanTech (Pre-seed)BioTech (Pre-seed)Therapeutics (Seed)Pharmaceuticals (Pre-seed)Health IT (Pre-seed)Pharmaceuticals (Seed)Health & Hospital Services (Pre-seed)FinTech (Pre-seed)ClimateTech/CleanTech (Seed)Digital Health (Seed)Pharmaceuticals (Seed)Digital Health (Pre-seed)ClimateTech/CleanTech (Pre-seed)BioTech (Pre-seed)BioTech (Seed)Health & Hospital Services (Pre-seed)Health & Hospital Services (Seed)Health IT (Seed)Health IT (Pre-seed)ClimateTech/CleanTech (Seed)FinTech (Seed)FinTech (Pre-seed)Digital Health (Seed)BioTech (Seed)Health & Hospital Services (Seed)Health IT (Seed)San Francisco Bay AreaFinTech (Seed)
Krishna Polu's Investments On Record (1)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Bicara Therapeutics | Series CDec 2023$170M Series BMar 2023$110M | $270M |
Krishna Polu's Media (1)
Krishna Polu's Experience
Executive in Residence Bioqube Ventures2023 - Present
Chief Executive Officer Commit Biologics2023 - Present
Director Board of Directors Sardona Therapeutics2023 - Present
Director Board of Directors Bicara Therapeutics2022 - 2023
Principal Red Tree Venture Capital2021 - 2023
Member Board Of Directors Frazier Lifesciences Acquisition Corporation2020 - 2022
EVP of R&D and Chief Medical Officer Equillium, Inc.2018 - 2021
Interim CEO Scout Bio2018 - 2018
Entrepreneur In Residence Frazier Healthcare Partners2017 - 2018
Chief Medical Officer Raptor Pharmaceuticals2015 - 2016
Chief Medical Officer CytomX Therapeutics2013 - 2014
Vice President, Clinical Development Affymax2009 - 2013
Executive Director, Clinical Development Amgen2005 - 2009
Krishna Polu's Education
Stanford University Graduate School of Business Certificate Directors Consortium
Harvard Medical School Fellowship in Nephrology
University of Colorado Anschutz Medical Campus Residency in Internal Medicine
The University of Texas Medical School at San Antonio MD
Stanford University BA Human Biology